• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘧啶基丙烯酰胺类作为抗肿瘤剂。抗生素稀疏霉素的类似物。

Pyrimidinylpropenamides as antitumor agents. Analogues of the antibiotic sparsomycin.

作者信息

Lin C C, Dubois R J

出版信息

J Med Chem. 1977 Mar;20(3):337-41. doi: 10.1021/jm00213a004.

DOI:10.1021/jm00213a004
PMID:845865
Abstract

A series of pyrimidinylpropenamides 9 and their oxidation products 10 was prepared, as analogues of sparsomycin (1), for antitumor evaluation. Syntheses involved condensation of the appropriate amino alcohol 5 with acid 8. The resulting sulfides 9 were then oxidized with NaIO4 or H2O2 to sulfoxides 10. Activity was studied in lymphocytic leukemia P-338 and KB cell culture. With the exception of the n-decyl analogue, all of the deoxygenated compounds 9 were inactive regardless of the stereochemical form. In the sulfoxide series 10, those compounds prepared with an L configuration at the asymmetric carbon were also inactive. The completely racemic sulfoxides, on the other hand, displayed substantial antitumor activity (ILS = 37-61% in P-388; ED50 = 1.2-2.4 mug/ml in KB) suggesting that both the presence of a sulfoxide moiety and a D configuration at the chiral carbon atom were structural requirements for a positive antitumor response. There appeared to be a large tolerance for the group substituted at the sulfoxide moiety, however.

摘要

制备了一系列嘧啶基丙烯酰胺9及其氧化产物10,作为稀疏霉素(1)的类似物用于抗肿瘤评估。合成过程包括适当的氨基醇5与酸8的缩合反应。然后用高碘酸钠或过氧化氢将所得的硫化物9氧化为亚砜10。在淋巴细胞白血病P - 338和KB细胞培养中研究了其活性。除正癸基类似物外,所有脱氧化合物9无论其立体化学形式如何均无活性。在亚砜系列10中,那些在不对称碳上具有L构型的化合物也无活性。另一方面,完全外消旋的亚砜显示出显著的抗肿瘤活性(在P - 388中ILS = 37 - 61%;在KB中ED50 = 1.2 - 2.4μg/ml),这表明亚砜部分的存在以及手性碳原子上的D构型都是产生阳性抗肿瘤反应的结构要求。然而,对于亚砜部分所取代的基团似乎有很大的耐受性。

相似文献

1
Pyrimidinylpropenamides as antitumor agents. Analogues of the antibiotic sparsomycin.嘧啶基丙烯酰胺类作为抗肿瘤剂。抗生素稀疏霉素的类似物。
J Med Chem. 1977 Mar;20(3):337-41. doi: 10.1021/jm00213a004.
2
Synthesis and biological evaluation of sparsomycin analogues.稀疏霉素类似物的合成与生物学评价
J Med Chem. 1983 Nov;26(11):1556-61. doi: 10.1021/jm00365a003.
3
Sparsomycin analogs. VI. Synthesis and antitumor activity of octylsparsomycin analogs.稀疏霉素类似物。VI。辛基稀疏霉素类似物的合成与抗肿瘤活性。
Chem Pharm Bull (Tokyo). 1989 Mar;37(3):688-91. doi: 10.1248/cpb.37.688.
4
Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growth.稀疏霉素及其类似物的构效关系。对无细胞系统中肽键形成以及L1210和细菌细胞生长的抑制作用。
J Med Chem. 1987 Feb;30(2):325-33. doi: 10.1021/jm00385a014.
5
The chiral synthesis and biochemical properties of electron rich phenolic sulfoxide analogs of sparsomycin.稀疏霉素富电子酚亚砜类似物的手性合成及生化性质
Biochem Biophys Res Commun. 1990 Jan 30;166(2):673-80. doi: 10.1016/0006-291x(90)90862-h.
6
Lipophilic analogues of sparsomycin as strong inhibitors of protein synthesis and tumor growth: a structure-activity relationship study.司帕索霉素的亲脂性类似物作为蛋白质合成和肿瘤生长的强效抑制剂:构效关系研究
J Med Chem. 1989 Aug;32(8):2002-15. doi: 10.1021/jm00128a051.
7
The development of sparsomycin as an anti-tumour drug.sparsomycin作为一种抗肿瘤药物的研发。
Anticancer Drug Des. 1988 Mar;2(4):333-7.
8
Effect of sparsomycin analogues on the puromycin-peptidyl transferase reaction on ribosomes.稀疏霉素类似物对核糖体上嘌呤霉素 - 肽基转移酶反应的影响。
J Med Chem. 1978 Feb;21(2):176-9. doi: 10.1021/jm00200a006.
9
Sparsomycin analogs. II. Synthesis and biological activities of 5-carboxy-6-methyluracil derivatives.稀疏霉素类似物。II. 5-羧基-6-甲基尿嘧啶衍生物的合成及生物活性
Chem Pharm Bull (Tokyo). 1983 Jan;31(1):135-43. doi: 10.1248/cpb.31.135.
10
Structure-activity relationships of sparsomycin and its analogues. Octylsparsomycin: the first analogue more active than sparsomycin.稀疏霉素及其类似物的构效关系。辛基稀疏霉素:首个比稀疏霉素活性更高的类似物。
J Med Chem. 1984 Mar;27(3):301-6. doi: 10.1021/jm00369a012.

引用本文的文献

1
Importance of the hydrophobic sulfoxide substituent on nontoxic analogs of sparsomycin.疏水亚砜取代基对稀疏霉素无毒类似物的重要性。
Antimicrob Agents Chemother. 1984 Apr;25(4):443-5. doi: 10.1128/AAC.25.4.443.